Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors

The genesis of the Benign Paroxysmal Positional Vertigo (BPPV) seems to be related to some metabolic factors. These factors, such as vitamin D, glucocorticoids, and even thyroid and growth hormones, can affect bone metabolism and the mineralization of otoconia. It also seems to link to factors relat...

Full description

Bibliographic Details
Main Authors: Joaquín Guerra, Jesús Devesa
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Journal of Otology
Subjects:
GH
Online Access:http://www.sciencedirect.com/science/article/pii/S1672293020300544
id doaj-334b5dab901e4ffca89026157673661b
record_format Article
spelling doaj-334b5dab901e4ffca89026157673661b2020-11-25T04:05:12ZengElsevierJournal of Otology1672-29302020-12-01154155160Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factorsJoaquín Guerra0Jesús Devesa1Otolaryngology, Medical Center Foltra, Travesía de Montouto 24, 15886, Teo, Spain; Corresponding author. Medical Center Foltra, Travesía de Montouto 24, 15886, Teo, Spain.Scientific Direction, Medical Center Foltra, Travesía de Montouto 24, 15886, Teo, SpainThe genesis of the Benign Paroxysmal Positional Vertigo (BPPV) seems to be related to some metabolic factors. These factors, such as vitamin D, glucocorticoids, and even thyroid and growth hormones, can affect bone metabolism and the mineralization of otoconia. It also seems to link to factors related to aging or nutritional habits. Besides, since the incidence of BPPV is quantitatively higher in women than in men, female sex steroids could be associated with this process. It could be useful to understand how these factors act in otoconial mineralization if we want to develop treatments aimed at preventing or delaying BPPV recurrences. In this review, we will analyze the role of these metabolic and hormonal factors in otoconial mineralization and in the treatment of BPPV.http://www.sciencedirect.com/science/article/pii/S1672293020300544Benign paroxysmal positional vertigoOtoconiaBone metabolismVitamin DEstrogensGH
collection DOAJ
language English
format Article
sources DOAJ
author Joaquín Guerra
Jesús Devesa
spellingShingle Joaquín Guerra
Jesús Devesa
Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
Journal of Otology
Benign paroxysmal positional vertigo
Otoconia
Bone metabolism
Vitamin D
Estrogens
GH
author_facet Joaquín Guerra
Jesús Devesa
author_sort Joaquín Guerra
title Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
title_short Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
title_full Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
title_fullStr Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
title_full_unstemmed Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
title_sort causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors
publisher Elsevier
series Journal of Otology
issn 1672-2930
publishDate 2020-12-01
description The genesis of the Benign Paroxysmal Positional Vertigo (BPPV) seems to be related to some metabolic factors. These factors, such as vitamin D, glucocorticoids, and even thyroid and growth hormones, can affect bone metabolism and the mineralization of otoconia. It also seems to link to factors related to aging or nutritional habits. Besides, since the incidence of BPPV is quantitatively higher in women than in men, female sex steroids could be associated with this process. It could be useful to understand how these factors act in otoconial mineralization if we want to develop treatments aimed at preventing or delaying BPPV recurrences. In this review, we will analyze the role of these metabolic and hormonal factors in otoconial mineralization and in the treatment of BPPV.
topic Benign paroxysmal positional vertigo
Otoconia
Bone metabolism
Vitamin D
Estrogens
GH
url http://www.sciencedirect.com/science/article/pii/S1672293020300544
work_keys_str_mv AT joaquinguerra causesandtreatmentofidiopathicbenignparoxysmalpositionalvertigobasedonendocrinologicalandothermetabolicfactors
AT jesusdevesa causesandtreatmentofidiopathicbenignparoxysmalpositionalvertigobasedonendocrinologicalandothermetabolicfactors
_version_ 1724435114010607616